141 related articles for article (PubMed ID: 37001578)
21. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
[TBL] [Abstract][Full Text] [Related]
22. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
23. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
24. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-26a alleviates tubulointerstitial fibrosis in diabetic kidney disease by targeting PAR4.
Qu G; Li X; Jin R; Guan D; Ji J; Li S; Shi H; Tong P; Gan W; Zhang A
J Cell Mol Med; 2024 Feb; 28(3):e18099. PubMed ID: 38164021
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
27. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
28. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
29. Jiedu Tongluo Baoshen formula enhances renal tubular epithelial cell autophagy to prevent renal fibrosis by activating SIRT1/LKB1/AMPK pathway.
Jin D; Zhao Y; Sun Y; Xue J; Li X; Wang X
Biomed Pharmacother; 2023 Apr; 160():114340. PubMed ID: 36738503
[TBL] [Abstract][Full Text] [Related]
30. Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7.
Gong M; Guo Y; Dong H; Wu W; Wu F; Lu F
Biomed Pharmacother; 2023 Dec; 168():115747. PubMed ID: 37864898
[TBL] [Abstract][Full Text] [Related]
31. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
32. Discovery of PRDM16-Mediated TRPA1 Induction as the Mechanism for Low Tubulo-Interstitial Fibrosis in Diabetic Kidney Disease.
Xu F; Jiang H; Li X; Pan J; Li H; Wang L; Zhang P; Chen J; Qiu S; Xie Y; Li Y; Zhang D; Dong Z
Adv Sci (Weinh); 2024 Feb; 11(7):e2306704. PubMed ID: 38072665
[TBL] [Abstract][Full Text] [Related]
33. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
34. YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis.
Yang T; Hu Y; Chen S; Li L; Cao X; Yuan J; Shu F; Jiang Z; Qian S; Zhu X; Wei C; Wei R; Yan M; Li C; Yin X; Lu Q
Cell Biol Toxicol; 2023 Apr; 39(2):391-413. PubMed ID: 35445903
[TBL] [Abstract][Full Text] [Related]
35. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.
Li Y; Hu Q; Li C; Liang K; Xiang Y; Hsiao H; Nguyen TK; Park PK; Egranov SD; Ambati CR; Putluri N; Hawke DH; Han L; Hung MC; Danesh FR; Yang L; Lin C
J Clin Invest; 2019 Mar; 129(3):1129-1151. PubMed ID: 30741721
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
[TBL] [Abstract][Full Text] [Related]
37. Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice.
Pang XX; Bai Q; Wu F; Chen GJ; Zhang AH; Tang CS
Kidney Blood Press Res; 2016; 41(4):434-49. PubMed ID: 27467277
[TBL] [Abstract][Full Text] [Related]
38. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Zheng Z; Guan M; Jia Y; Wang D; Pang R; Lv F; Xiao Z; Wang L; Zhang H; Xue Y
Sci Rep; 2016 Nov; 6():37492. PubMed ID: 27874055
[TBL] [Abstract][Full Text] [Related]
39. CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway.
Li Y; Zhang Y; Shi H; Liu X; Li Z; Zhang J; Wang X; Wang W; Tong X
Mol Med; 2023 Oct; 29(1):146. PubMed ID: 37884902
[TBL] [Abstract][Full Text] [Related]
40. Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells.
Zhang X; Liang D; Chi ZH; Chu Q; Zhao C; Ma RZ; Zhao Y; Li H
Int J Mol Med; 2015 Jun; 35(6):1747-54. PubMed ID: 25872526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
